📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
48 announcements match the current filters (relevance ≥ 5).
Gem Aromatics Bags $1M Export Orders and Starts New Product Production at Dahej Facility
Gem Aromatics has secured new export orders totaling USD 1 million from the USA and Europe, signaling a revival in international demand following tariff reductions and trade agreements. The company has also commenced commercial production of new products, including cooling agents and Citral derivatives, at its Dahej greenfield facility via its subsidiary, Krystal Ingredients. This expansion is part of a larger strategy to utilize an additional 9,229 MTPA capacity currently under pilot run. Furthermore, the company expects to complete the manufacturing setup for MEHQ catalysts by Q4FY26.
Key Highlights
Received new export orders worth USD 1 million from customers in the USA and Europe
Commenced commercial production of GEM Cool 5 (Cooling Agents) and Safranal at Dahej facility
Company is scaling up with 9,229 MTPA additional capacity currently under pilot run
Manufacturing of Catalyst for MEHQ is on track for completion by Q4FY26
Export revival driven by proposed EU FTA and easing of US tariff headwinds
👀 What to Watch
Investors should track the successful transition of the 9,229 MTPA pilot capacity into full commercial operations as it will significantly boost revenue. The recovery in high-margin export markets is a positive indicator for bottom-line growth in the coming quarters.
Gem Aromatics Schedules Plant Visit for 20+ Institutional Investors at Dahej Facility
Gem Aromatics Limited has announced a plant visit for over 20 institutional investors and analysts on February 24, 2026. The visit will take place at the company's Unit 3 facility in Dahej, Gujarat, from 11:30 AM to 3:30 PM. Notable participants include HDFC Securities, Lucky Investment Managers, and Prabhudas Liladhar. The company intends to use its Q3 & 9MFY26 investor presentation for the interaction, highlighting its operational setup to the investment community.
Key Highlights
Plant visit scheduled for February 24, 2026, at the Dahej, Gujarat manufacturing unit.
Over 20 major institutional investors and fund houses confirmed for the site visit.
Participating firms include HDFC Securities, SageOne Investments, and Nirmal Bang Securities.
Discussions will be based on the existing Q3 and 9MFY26 investor presentation.
👀 What to Watch
Investors should watch for potential research coverage or updates from the participating institutional firms following the site visit. The significant interest from multiple fund houses suggests a positive outlook on the company's manufacturing capabilities.
Gem Aromatics Q3 FY26: Dahej Facility Commissioned, Targets ₹1,100 Cr Revenue by FY28
Gem Aromatics reported Q3 FY26 consolidated revenue of ₹78.9 crore, with gross margins improving significantly to 23% from 14% in the previous quarter. The company successfully commissioned its Greenfield Dahej facility in December 2025, marking a 3x capacity expansion to 16,000 MTPA. Despite a consolidated net loss of ₹5 crore due to high depreciation from the ₹250 crore capitalized capex, management provided strong guidance. The company aims for ₹1,050-1,100 crore in revenue and 16-18% EBITDA margins by FY28 as it diversifies into high-value phenol and cooling agents.
Key Highlights
Commissioned Greenfield Dahej facility on Dec 11, 2025, increasing total capacity 3x to 16,000 MTPA
Consolidated gross margins improved to 23% in Q3 FY26 from 14% in the previous quarter
Incurred ₹250 crore of the planned ₹270 crore total capex for the Dahej facility expansion
Management targets revenue of ₹1,050-1,100 crore and EBITDA margins of 16-18% by FY28
Reported a consolidated net loss of ₹5 crore for Q3 FY26, primarily due to a ₹8.7 crore non-cash depreciation charge
👀 What to Watch
Investors should focus on the capacity utilization ramp-up at the Dahej plant and the successful commercialization of phenol derivatives in Q1 FY27. While current profitability is masked by high depreciation, the long-term growth trajectory and diversification away from mint-centric products are positive indicators.
Gem Aromatics Q3FY26: Dahej Plant Commissioned; Targets Rs 1,100 Cr Revenue by FY28
Gem Aromatics reported a consolidated revenue of Rs 78.9 Cr for Q3FY26, a 19% YoY decline attributed to tariff uncertainties and GST-related changes. The company achieved a major milestone by commissioning its greenfield Dahej facility on December 11, 2025, with a total capex of Rs 270 Cr. While consolidated PAT showed a loss of Rs 5 Cr due to a high non-cash depreciation charge of Rs 8.7 Cr post-capitalization, standalone EBITDA margins improved to 9.1%. Management has provided a strong long-term guidance, targeting revenues of Rs 1,050-1,100 Cr and EBITDA margins of 16-18% by FY28.
Key Highlights
Commissioned greenfield Dahej plant with 10,829 MTPA capacity on Dec 11, 2025.
Consolidated revenue declined 19% YoY to Rs 78.9 Cr, while standalone EBITDA margin rose to 9.1%.
Reported consolidated loss of Rs 5 Cr driven by Rs 8.7 Cr in non-cash depreciation from new facility.
Management targets aggressive growth to Rs 1,050 - 1,100 Cr revenue by FY28.
Diversifying into high-value cooling agents and phenol derivatives to reduce dependency on mint products.
👀 What to Watch
Investors should focus on the capacity utilization and ramp-up of the Dahej facility in Q4FY26 as the primary growth driver. While the current bottom line is impacted by depreciation, the transition toward high-margin specialty chemicals and the FY28 guidance suggest significant long-term potential.
Gem Aromatics Q3 Results: Consolidated PAT Slips to Loss of ₹5 Cr on High Capex Depreciation
Gem Aromatics reported a consolidated net loss of ₹5.0 crore for Q3 FY26, a sharp decline from a ₹7.5 crore profit YoY, primarily due to ₹8.7 crore in depreciation following the capitalization of its new Dahej facility. Consolidated revenue fell 18.5% YoY to ₹78.9 crore, impacted by external headwinds like GST changes and tariff uncertainties that led to customer inventory optimization. Despite the short-term bottom-line pressure, the company successfully commenced commercial production at its ₹270 crore Dahej plant in December 2025. Management has issued a long-term guidance targeting revenue of ₹1,050-1,100 crore by FY28.
Key Highlights
Consolidated Q3 revenue declined 18.5% YoY to ₹78.9 crore, while 9MFY26 PAT plummeted to ₹0.4 crore from ₹25.8 crore YoY.
Reported a consolidated net loss of ₹5.0 crore in Q3 FY26, heavily impacted by ₹8.7 crore in non-cash depreciation charges.
Capitalized ₹250 crore of the total ₹270 crore capex for the Dahej facility, which will increase total capacity to approximately 16,000 MTPA.
Commenced commercial production of cooling agents (WS-23, WS-03) and clove derivatives at the Dahej plant on December 11, 2025.
Management targets FY28 revenue of ₹1,050-1,100 crore with EBITDA margins of 16-18% as asset utilization improves.
👀 What to Watch
The current net loss is primarily an accounting impact from high depreciation of a major new facility; investors should monitor the ramp-up in capacity utilization at Dahej. The long-term investment case depends on the company's successful transition into high-value specialty chemicals and meeting its ambitious FY28 revenue targets.
Gem Aromatics Q3 Standalone PAT Drops 72% YoY to ₹41.28 Million; Revenue Declines
Gem Aromatics reported a weak set of numbers for the quarter ended December 31, 2025, with standalone revenue from operations falling to ₹839.01 million from ₹891.21 million YoY. Net profit saw a sharp decline of 72% YoY, dropping from ₹148.41 million to ₹41.28 million. In a notable move, the Executive Directors have waived their remuneration for FY 2025-26, citing a challenging business environment and poor financial performance. The company has fully utilized its IPO proceeds of ₹1,628.63 million, primarily for debt repayment.
Key Highlights
Standalone Revenue from operations decreased to ₹839.01 million in Q3 FY26 compared to ₹891.21 million in Q3 FY25.
Standalone Net Profit (PAT) plummeted 72% YoY to ₹41.28 million from ₹148.41 million.
Earnings Per Share (EPS) fell significantly to ₹0.79 from ₹3.10 in the same quarter last year.
Executive Directors waived their entire remuneration for FY 2025-26 due to the current business environment.
The company fully utilized ₹1,400 million from IPO proceeds for debt repayment of the company and its subsidiary, Krystal Ingredients.
👀 What to Watch
Investors should exercise caution as the sharp decline in both revenue and profitability indicates significant operational headwinds. While the management's salary waiver shows alignment with shareholders, the underlying business performance remains under pressure.
Gem Aromatics Starts Commercial Production of Cooling Agents & Clove Products at Dahej Facility
Gem Aromatics has commenced commercial production of WS-23 and WS-03 cooling agents, clove oil, and eugenol at its new greenfield facility in Dahej, Gujarat. The facility is operated by its wholly-owned subsidiary, Krystal Ingredients Private Limited, and aims to reduce the company's dependence on mint-based products. With a total installed capacity of 5,346 MTPA across three sites, the company serves over 225 domestic and 44 global customers, including major brands like Colgate-Palmolive and Dabur. This expansion into high-value aroma molecules is a strategic move to diversify the product portfolio and improve margins.
Key Highlights
Commencement of commercial production for WS-23 & WS-03 cooling agents and clove-derived products at the Dahej facility.
Strategic diversification to reduce reliance on Mint derivatives by expanding into Citral and Phenol derivatives.
The company operates with a total installed capacity of 5,346 MTPA across facilities in UP, Gujarat, and Daman & Diu.
Serves a global client base across 18 countries, including tier-1 brands like Symrise, Patanjali, and SH Kelkar.
The new facility utilizes advanced process technology to deliver high-purity products for oral care, pharma, and cosmetic industries.
👀 What to Watch
Investors should monitor the revenue contribution and margin improvements resulting from this new facility, as value-added cooling agents typically command higher premiums than traditional mint products.
Gem Aromatics Starts Commercial Production of Cooling Agents & Clove Products at Dahej Facility
Gem Aromatics Limited has officially commenced commercial production of WS-23 and WS-03 cooling agents, as well as Clove Oil and Eugenol, at its new greenfield facility in Dahej, Gujarat. The operations are managed through its wholly-owned subsidiary, Krystal Ingredients Private Limited. This expansion is a strategic move to diversify the company's portfolio beyond mint derivatives into high-value segments like Citral and Phenol derivatives. With a total installed capacity of 5,346 MTPA, the company aims to serve its base of 225+ domestic and 44 global customers more effectively.
Key Highlights
Commenced commercial production of high-purity cooling agents (WS-23, WS-03) and Clove derivatives at the Dahej facility.
The facility is operated under Krystal Ingredients Private Limited, a 100% owned subsidiary of Gem Aromatics.
Strategic diversification aimed at reducing dependence on Mint derivatives by expanding into niche, value-added aroma chemicals.
Total company-wide installed capacity stands at 5,346 MTPA across three manufacturing locations in India.
The company serves major brands including Colgate-Palmolive, Dabur, Patanjali, and Symrise across 18 countries.
👀 What to Watch
Investors should view this as a positive growth catalyst that could improve margins through value-added products; monitor the revenue contribution from the Dahej facility in upcoming quarterly results.
